文献速递质量管理与危急值

价值导向评分在实验室医学中的欧洲试点研究

The value-based score in laboratory medicine: results of a European pilot study.
PubMed 文献 · Clin Chem Lab Med · 2026-06-22

欧洲临床化学与实验室医学联合会(EFLM)价值导向评分委员会设计价值导向评分(V-BS),在12家不同规模的欧洲临床实验室试点。总分范围44.64至86.18,均值68.90,中位数71.21;全程可追溯性和实验室信息质量相关指标得分最高,临床互动域得分最低。

要点

  • V-BS总分范围44.64至86.18,均值68.90,中位数71.21。
  • 全程可追溯性和实验室信息质量指标得分最高。
  • 临床互动域在所有参与实验室中得分最低。

核心结论

  • 12家欧洲临床实验室试点显示对V-BS倡议兴趣浓厚,多数可追溯性和信息质量指标表现满意。
  • 临床互动相关指标 consistently 得分最低。

研究设计与样本

  • V-BS由EFLM价值导向评分委员会专家设计,在12家不同规模的欧洲临床实验室试点。
  • 参与实验室完成涵盖五个领域的结构化Excel问卷,每项要求评分0至1并加权生成百分制总分。
  • 采用描述性统计总结总体和领域特异性表现。

主要发现

  • 所有受邀实验室完成试点评估。
  • 总分范围44.64至86.18,均值68.90,中位数71.21。
  • 全程可追溯性和实验室信息质量相关指标得分最高。
  • 临床互动域 consistently 得分最低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Value in healthcare has been defined as the ratio between clinical outcomes and costs, providing a valuable framework for laboratory medicine as well. Implementing this concept in laboratory medicine - referred to as Value-Based Laboratory Medicine (VBLM) - requires a shift from volume-driven activities to outcome-oriented practice. In particular, the value-based score (V-BS) represents a pragmatic tool for assessing and benchmarking laboratory performance. METHODS: The V-BS was designed by the experts of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Committee on the Value-Based Score (C-BS) and piloted in 12 European clinical laboratories of different sizes. Participating laboratories completed a structured Excel-based questionnaire covering five domains. Scores were assigned from 0 to 1 for each requirement and weighted to generate a final score out of 100. Descriptive statistics were used to summarize total and domain-specific performance. RESULTS: All invited laboratories completed the pilot evaluation. Total scores ranged from 44.64 to 86.18, with a mean of 68.90 and a median of 71.21. The highest scores were observed for indicators related to traceability throughout the total testing process and quality of laboratory information, whereas clinical interaction was consistently the weakest domain. CONCLUSIONS: The data reported by the clinical laboratories participating in the pilot study demonstrate strong interest in this initiative. Although relevant differences in value-based laboratory performance were observed across the 12 participating sites, overall satisfactory performance was achieved for most indicators related to traceability and quality of laboratory information. In contrast, indicators related to clinical interaction consistently received the lowest scores.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Plebani M, Banfi G, Ucar KT, et al. The value-based score in laboratory medicine: results of a European pilot study. Clin Chem Lab Med. 2026. PMID: 42323723. doi:10.1515/cclm-2026-0810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。